Updates in Skin Cancer & Melanoma

FDA Receives Pre-Market Approval Module for Novel Recurrent CSCC Therapy

Frontline Sorafenib Shows Promising Outcomes in Metastatic Uveal Melanoma

Melphalan/Hepatic Delivery System Displays Efficacy in Uveal Melanoma